October 26, 2016 12:29 PM ET


Company Overview of Inhibitex, Inc.

Key Executives for Inhibitex, Inc.

NameBoard RelationshipsTitleAge
Russell H. Plumb M.B.A.19 RelationshipsChief Executive Officer, Chief Financial Officer and Principal Accounting Officer57
Demetrios Kydonieus 7 RelationshipsPresident and Director--
Joseph M. Patti M.S.P.H., Ph.D.9 RelationshipsFounder, Chief Scientific Officer, Senior Vice President of Research & Development and Assistant Secretary52
Geoffrey W. Henson Ph.D.No RelationshipsSenior Vice President of Drug Development68
Seth Hetherington M.D.No RelationshipsChief Medical Officer and Vice President of Clinical Development64

Inhibitex, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Demetrios Kydonieus 7 RelationshipsInhibitex, Inc.--
Jeffrey Galik 18 RelationshipsZymoGenetics, Inc.--
Erik De Clercq M.D., Ph.D. 7 RelationshipsInhibitex, Inc.--
Robert T. Schooley M.D. 96 RelationshipsGilead Sciences Inc.--
Charles Flexner M.D. 7 RelationshipsInhibitex, Inc.--
View All Board Members

Inhibitex, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board M.D., Ph.D.Erik De Clercq7 Relationships5 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation$364.0K
Total Value of Options
Compensation as of Fiscal Year
Inhibitex, Inc. CEO Compensation
Industry Average


ChemoCentryx Promotes Susan M. Kanaya to Position of Executive Vice President, Chief Financial and Administrative Officer and Secretary
October 25, 2016 8:02 PM ET
China Regenerative Medicine International Limited Appoints Chen Chunguo as President, Effective October 25, 2016
October 25, 2016 10:35 AM ET
Agendia Announces Appointments to Medical Advisory Board
October 25, 2016 10:20 AM ET
Global Blood Therapeutics, Inc. Announces Resignation of Dr. Eleanor Ramos as Chief Medical Officer
October 24, 2016 8:34 PM ET
GenVec, Inc. Announces Board Changes
October 24, 2016 8:33 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Inhibitex, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.